Navigation Links
MicroCHIPS Announces 35th U.S. Patent for Microreservoir-Based Drug Delivery Systems
Date:3/29/2011

WALTHAM, Mass., March 29, 2011 /PRNewswire/ -- MicroCHIPS, Inc., a developer of innovative drug delivery devices and biosensors, today announced that the U.S. Patent Office and Trademark Office has granted U.S. Patent No. 7,892,221, Method of Controlled Drug Delivery from Implant Device. This patent in conjunction with U.S. Patent No. 7,070,590 provides broad coverage for the design and fabrication of reservoir-based medical devices used for implantable drug delivery systems.

MicroCHIPS' intellectual property originated as patent filings at the Massachusetts Institute of Technology, by professors and MicroCHIPS cofounders Robert Langer and Michael Cima, and cofounder John Santini. These patents are licensed to MicroCHIPS, which has continued to develop and enhance the reservoir-based technology and to generate additional intellectual property covering microreservoirs, controlled release components and systems, and biosensors. As a result, MicroCHIPS' current patent portfolio includes more than 80 patents and more than 50 pending applications, covering the U.S., Canada, various countries in Europe and Asia, as well as Australia.

"The granting of this patent provides the fundamental building blocks for programmable medical drug delivery implants to address various diseases such as diabetes, osteoporosis, heart disease, and cancer," said Robert Langer, ScD, Institute Professor at the David H. Koch Institute for Integrative Cancer Research at MIT.

MicroCHIPS' miniaturized systems are adaptable to implants and catheters as well as on-body delivery systems, external pumps, pens and infusion systems. Currently, the MicroCHIPS technology is embodied in the company's medical implants that are part of a clinical trial to treat osteoporosis in women. The trial is evaluating the pharmacokinetics of precise delivery of human parathyroid hormone (hPTH 1-34) from a programmable, wireless implanted device.

"This patent and technology portfolio combined with the on-going MicroCHIPS clinical trial focused on delivery of human parathyroid hormone will demonstrate the viability of controlled release from programmable or pre-programmable devices," said Michael Cima, PhD, the Sumitomo Electric Industries Professor of Engineering at the David H. Koch Institute for Integrative Cancer Research at MIT.

About MicroCHIPS

MicroCHIPS, Inc. is pioneering programmable implanted devices designed to improve the health of millions of people with critical conditions that require careful monitoring and therapy. MicroCHIPS' technologies enable the creation of in- and on-body devices that can sense vital biochemical changes, deliver potent drug therapies and communicate using wireless technologies. The technologies use microreservoir arrays to hermetically store and protect pharmaceuticals or sensors for extended periods of time. The reservoir arrays are compatible with microprocessors, wireless communications and sensor feedback loops to provide precise, dynamic control of delivery or sensing.


'/>"/>
SOURCE MicroCHIPS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MicroCHIPS Named 2010 Technology Pioneer by World Economic Forum
2. MEDRAD® Announces New Head of Interventional Business
3. Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective
4. WaferGen Announces Data Presentations From Newly Launched High-Throughput SmartChip Human microRNA Panel V2 at Scientific Conferences, Including AACR
5. Boston Scientific Announces Its ACC 2011 Schedule
6. Tris Pharma Announces Availability of the MyKidz® Iron Product Line - the Best Tasting Iron Supplements
7. Dendreon Announces Webcast Presentations at Upcoming Conferences
8. Diversified Medical Equipment & Supplies Corporation Announces New Home Care Medical Supply Division
9. Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans
10. JHP Pharmaceuticals Announces Multi-Year Contract Manufacturing Agreement
11. Ascension Orthopedics Announces Market Release of TITAN™ Modular Shoulder Fracture Prosthesis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... Aug. 7, 2017  Endo International plc (NASDAQ: ... to resolve virtually all known U.S. mesh product liability ... resolve the known remaining U.S. claims at reasonable values. ... in the fourth quarter of 2017 and continuing through ... second quarter 2017 results, the Company intends to increase ...
(Date:8/3/2017)... DIEGO , Aug. 3, 2017  Opioid addiction ... diseases driving up healthcare costs and threatening outcomes, were ... lab supply and IVD industry that support them, met ... care market researcher said that drugs of abuse, procalcitonin ... and sessions at the organization,s 69th meeting in ...
(Date:8/2/2017)... , Aug. 2, 2017  Life Flight Network and ... The agreement improves patient care and operational efficiency for patients ... Springfield , Cottage Grove , and ... medical transportation. PeaceHealth and Life Flight Network work collaboratively to ... during transport, or when a time sensitive emergency exists. ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... 2017 , ... LabRoots , the leading provider of educational and interactive ... to announce Andrew Ly as the winner of the LabRoots Summer Textbook scholarship, awarding ... Ly, who is in his third year at the University of California, Los Angeles ...
(Date:8/16/2017)... ... 2017 , ... SGNA Standards of Infection Control in Reprocessing ... between patient procedures and before storage, is a requisite practice crucial to the ... prevention of disease transmission and nosocomial infection as cleaning and HLD.” The ...
(Date:8/16/2017)... VERO BEACH, Fla. (PRWEB) , ... August 16, ... ... living development and management company based in Vero Beach, announced today that two ... Florida Argentum, an organization that represents professionally managed senior living communities in Florida. ...
(Date:8/16/2017)... , ... August 16, 2017 , ... TopConsumerReviews.com recently gave ... Lab Testing . , The healthcare industry in the United States has undergone major ... the days of needing to have a doctor’s order to get a blood test ...
(Date:8/16/2017)... ... August 16, 2017 , ... Women’s ... chronic pelvic pain. In addition to oncology services, the new center will ... menorrhagia (abnormal heavy bleeding during menstruation), uterine fibroids, and uterine and pelvic adhesions ...
Breaking Medicine News(10 mins):